More than 23,000 men, women, and children die in the US every year from antibiotic-resistant infections, while over 4,000 Americans perish from influenza annually. In addition, over 100 million suffer from chronic pain and 3.9 million adults in the US are diagnosed with liver disease. Shionogi, an international pharmaceutical firm, has dedicated their business to supplying the best possible medicines to protect the health and well-being of patients around the world.
With over 50 years of anti-infective research experience, Shionogi has helped revolutionise the development of antibacterial and anti-viral treatments. They are also pursuing the development of new treatments in other areas of high medical need, including inflammatory pain, neuropathic pain, Alzheimer's disease, and ADHD.
OryxAlign are delighted to announce that their technical expertise and dedicated support now underpins the heart of Shionogi's work. By providing award-winning support and technology to Shionogi, OryxAlign ensure that their vital research is both available and secure, enabling their life-changing medical advancements to continue.
Welcome to the OryxAlign family, Shionogi!